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Abstract
Background. European Union strategies and programmes identify research and innovation as a
critical dimension for future economic and social development. While European research policy
emphasises support for industry, the health field includes not-for-profit civil society organisations
providing social innovation. Yet the perspectives of civil society organisations towards health
research in Europe are not well understood.
Methods. STEPS (Strengthening Engagement with Public Health Research) was funded by the
European Commission’s Science in Society research programme. Within the study, we
interviewed by telephone respondents of 13 European health civil society organisations which
represented collectively local and national organisations
Results. Research was valued positively by the respondents. Health civil society organisations
did not seek to do research themselves, but recognised the opportunity of funds in this field and
welcomed the possibility of collaborating in research, of using the results from research and of
providing input to research agendas. Links between research and users provides knowledge for
the public and improves impacts on policy. Research and evaluation can help in demonstrating
the benefit of innovative activities, and give support and legitimacy. However, the cultures of,
and incentives for, researchers and health civil society organisations are different, and
collaboration requires building trust, a shared language, and for the power relations and
objectives to match.
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Conclusions. Health civil society organisations contribute social innovation in organising
services and activities such as advocacy that cannot be satisfactorily met by industry. Engaging
civil society organisations in research and innovation will strengthen the European Research
Area.
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Introduction
In its forward strategy for 2014-2020, the European Union identifies research and innovation as
critical for economic and social development, and has stated that, along with industry and the
public sector, civil society should contribute [1]. The European Commission has proposed an
‘Innovation Partnership on Active and Healthy Ageing’, linking programmes for health, research
and enterprise [2]. Although the European Commission emphasises collaboration with business
as the primary force for economic innovation, the objectives of education and health require
broader perspectives of social innovation [3]. We have investigated the perspectives for research
of health civil society organisations.
Civil society organisations (CSOs) in the definition of the European Commission are ‘non-
governmental, non-profit organisations that do not represent commercial interests, and pursue a
common purpose in the public interest’ [4]. Complementing the major contributions of the public
sector and business to research, CSOs form an important ‘third way’ in contributing social values
in decision-making and services [5]. The Open Society Foundation [6] has supported CSOs in
public health in central European countries, and the European Public Health Association
(EUPHA) has built alliances in Eastern Europe and Central Asia [7] and assessed research
priorities of CSOs [8]. However, while links between civil society and research have been
investigated in low and middle-income countries [9], and gained support through the Global
Forum for Health Research [10], there has been little published on research and health civil
society organisations in Europe.
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The European Commission’s Research Directorate, in its Seventh Framework Research
Programme for Science in Society (2007-2013), developed a theme for the role of civil society
[11], and a seminar on science and civil society organisations was held in Brussels in 2008 [4].
The work reported in this paper was undertaken within STEPS (Strengthening Engagement in
Public Health Research, an EU Research Support Action proposed and funded through a
competitive call from the Science in Society programme), and was informed by the seminar [12].
STEPS was developed in a partnership including the European Public Health Association
(EUPHA), and built on previous work with national public health associations analysing research
structures [13] and the priorities for research of national public health associations [14]. EUPHA
is a member of the European Commission Health and Consumer Directorate’s European Heath
Policy Forum, which meets twice yearly for dialogue with civil society organisations [15], and
through which our study was able to identify health CSO links to public health research.
Methods.
The European Health Policy Forum has around 40 invited member organisations [15],
representing civil society groups, professional groups, patient organisations and industry. With
the support of the European Commission’s officer responsible for the Forum, we identified
sixteen Forum members complying with the definition of a civil society organisation. We
included organisations representing both public health and patient concerns (see Acknowledgements), but
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not where their concern was primarily individualistic or supported commercial (e.g. pharmaceutical)
interests.
The European Commission’s seminar with civil society organisations [4] brought together
around 60 researchers and European science administrators across social fields to discuss issues
for the Science in Society programme. From this, and project discussions, we determined issues
for an open-ended questionnaire to investigate each civil society organisation’s experience of
involvement in research, their involvement in the development of national and European
research agendas, issues in collaboration between researchers and health CSOs, and the needs
and opportunities for public health research. We approached each organisation initially by email
to request their participation, sent the questionnaire, and then arranged a telephone interview,
supported by email, to gain replies. Thirteen organisations replied. Each respondent was a staff
member in, and spoke on behalf of, their European civil society organisation (see list in
Acknowledgements). The telephone interviews were conducted by one author [DB] and
recorded on interview sheets. Our report follows the order of the questions.
The Treaty of the European Union Article 168 gives ‘improving public health’ as a primary goal
[16]. Although ‘public health’ has a different meaning across languages and countries [17], our
broad approach includes population and system level policy and practice (including health
systems, health determinants and health promotion). We found generally, in the responses to the
questionnaire, that the word ‘health’ reflected this approach, in contrast to ‘medicine’ which
implied treatment and a more bio-medical model, although some of our responding organisations
represented patient (sickness) rather than citizen (health) perspectives. The Treaty Article 179
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also requires the EU to undertake ‘research’ on behalf of all its policy areas [16], and the
Commission’s Directorate of Research delivers this responsibility through multiannual
Framework Research Programmes. The Health Directorate’s Health Programme [18], which is of
direct interest to civil society organisations, provides for demonstration and dissemination of
good practice. However, where civil society organisations are working with researchers, the
separation is not strong, and both terms – research and project – are used.
Results
1. Description of the organisations
All of the responding organisations had considerable experience working within the health field.
The oldest health civil society organisation had been established for 48 years, and the youngest
for seven years. The organisations usually had membership from national networks, varying
from 23 to over 400 member organisations, so that the number of individuals represented by
these 'umbrella' organisations was large, and relatively representative of the EU.
We asked the responding organisations how they described their legal status – as NGO (non-
governmental organization) or CSO (civil society organization) – and their opinion on the
Science-in-Society programme definition of “civil society organisations”. Did it sound more
positive than “non-governmental”, which includes negative wording? Was it better or not to refer
directly to government or to society? Nine out of 13 participants named their organisation as an
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NGO, three as a CSO and one said it is not-for-profit organisation rather than either of the other
titles. Most organisations were not concerned how they are named, but are more used to calling
themselves NGOs (Table). All said that they are not-for-profit.
Current involvement of CSOs in the research area
The mission of most health CSOs is the day-to-day support of their members, and dissemination
of information including research results to members and in their work on EU health policy.
They do not have much knowledge about how to do research and science themselves, but the
majority said they have experience in cooperating with researchers as partners in projects. Larger
representative organisations have commissioning and fund-raising for the research among their
goals and missions. Four organisations have participated in the setting-up research agendas, and
two organisations had experience in planning, designing and raising funds for research.
Representatives with some organisations have also participated as experts on ethical committees
of research projects.
CSOs knew about some funds available for research, projects and programs from the .
Euoropean Commission, including the Seventh Framework Research Programme, the Health
Programme, the Innovative Medicines Initiative, the Leonardo da Vinci programme (for
mobility), and the European Partnership Action Against Cancer (established by the European
Commission Directorate for Health and Consumers, and including industry and patient
associations). Responding organisations suggested that "there is more available than we pick up”
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regarding their involvement in the research field. Their reasons for not being more involved in
these projects included lack of capacity and knowledge to write applications.
Possibilities for CSOs in new and old EU member states
Respondent organisations differed in their view whether CSOs from new EU member states are
equally involved in the EU research projects compared with the old EU member states. Half
were sure that the chances were the same, or potentially even better, because the European
Commission promotes research and projects in new member states. Other respondents were more
cautious: “In principle yes, but as a matter of fact – maybe not.” Even if the need for
involvement is recognized and supported by the Commission, the old member states have more
connections, they know better how to write project proposals and which people to involve. Some
researchers have their networks and they are very good in writing projects. However, in the new
member states, some researchers lack knowledge about procedures and contacts, lack long term
experience in coordinating, lack information about opportunities, have poorer financial
possibilities, and face difficulties in the heavy bureaucracy of EU projects. They can be involved
as partners, but their capacity to take a leading role may be limited.
2. CSOs involvement in the development of national and European research agendas
Responding organisations considered that there was some involvement of CSOs in developing
national and European research agendas, but that it was insufficient or even insignificant. Civil
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Society organisations recognize good intentions of the European Commission’s Directorates for
Research and for Health in improving cooperation with them. “It would be fair to say that if we
are being heard, if we are well prepared and have good arguments in the right time, and if we
meet the right people, then there are good chances.” For other organisations, involvement had
happened by chance, without a process. In some countries, national networks have very good
collaboration with their governmental bodies, which may involve them in setting research
agendas - although these are mostly driven by governments or universities. Otherwise, there may
be a wish to get an opinion from a CSO, but that doesn’t change the research agenda, and they
don’t get feedback.
CSO cooperation with researchers.
Almost all CSOs responded that their organisation’s partnership with the researchers was good or
fairly good. Cooperation in most of cases was seen as very complementary: academics provide
their knowledge, CSOs contribute their expertise, their partners and links with broader society.
But for some, the difference between the research world and that of CSOs is expressed as a
challenge: “As we are so different? - it is difficult to find harmony."
Finding mutual goals is of crucial importance: “That is the challenge, that is the key role”.
While CSOs usually have a clear mission, that is less the case for research activities, which
sometimes based more on individual or personal interests and ambitions. There are also
challenges in cooperation between CSOs and medical staff – these two cultures are very
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different. CSOs and researchers also belong to cultures that interpret public health differently,
although the challenges are less in the cooperation between social scientists and CSOs.
Building trust. Respondents observed that CSOs do not trust all researchers – especially those
which are supported by industry. “It is much easier to trust research that is supported by a public
body.” CSOs are also concerned when research does not respect the real needs of intended users,
but is driven by the ambition of researchers, or industry pushing for certain technology and
treatments for market reasons. Sometimes researchers lack confidence in CSOs’ expertise – and
vice versa. “Sometimes CSO participation looks good, but researchers frequently do not
understand or undervalue the expertise from CSOs.”
Language is a challenge, in two ways: linguistic and understanding. English language is widely
used in the world of research, and most research is published in English; but this can cause
problems for those for whom it is not a native language. Many European CSOs’ individual
members do not speak enough English to cope with scientific articles in English, especially in
very technical areas. These differences are more easily resolved between social scientists and
CSOs than between medical setting and CSOs.
Finding resources. Financial and time resources were an important challenge for CSOs to be
involved in the research. The need for resources for meaningful participation should not be
underestimated: often CSOs are expected to be involved in research without suffficient
resources. CSOs are usually volunteer organisations, and researchers have to reserve funding for
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them. In addition, the co-funding rules of the European Commission, do not allow volunteers’
unpaid time to be regarded as financial contributions to projects.
How partners are found
The most common start for links is by the researchers contacting the CSOs, because their
involvement would be “good for the project”. These informal ways seem to be very practical and
used much: “mouth to mouth” recommendations and networking of contacts. CSOs that
commission research also find the researchers in the same way: many of the contacts are
established through previous experience in the research field, with partnerships are made over
years. Also partners are found at conferences, dissemination events of other projects and
European Commission open days. Several CSOs have an expert advisory group which includes
researchers, which is a useful and succesful pattern for exchanging knowledege and networking.
3. Cooperation between researchers and health CSOs
The questionnaire asked about the benefits of cooperation between researchers and CSOs
through propositions and conclusions from the European Commission’s Science-in-Society
seminar (6) bringing together researchers and representatives of civil society organisations.
“CSOs help to develop a user-led agenda for the research” was agreed by majority of
participants, although for some, it was expressed in the form of desire: “Broadly it should be
true, but I am not sure if it happens”. The concern is that research is too often not built around
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the real needs of people. For example, patients may not be consulted on how they live with their
disease, what specific aspects they would like research to address, and how research outcomes
can impact their daily life - not just their health status. Setting a research agenda is seen to be a
very important issue from CSOs’ perspective: programmes and projects need to be based on the
most recent information and developments to be as effective as possible. European CSOs wish
research and new technology to be user-driven. CSOs have the knowledge of the specific
challenges in the field. They can phrase research questions, and provide insights on
developments or trends needing answers. By knowing political needs and strategies, they can
also contribute to policy making. They see the overview at EU level which sometimes
researchers see in a more narrow perspective.
“CSOs can bring results back to civil society” was agreed by all the participants. CSOs have
more contacts and that is their aim – to collect and disseminate information. The results from
research are often not known to those who are the intended beneficiaries of the research. CSOs
can use their channels and networks to inform their constituencies, and communicate the results
in a manner that is understandable to lay people. Research findings often stay in scientific
journals where people in the scientific community know of it, but few others. Dissemination,
however, cannot be done automatically and takes resources.
"CSOs help to spread knowledge through new channels". CSOs agreed that they have
channels that researchers usually don’t have, and vice versa. CSOs can spread knowledge
through their members and communicate with policy makers, at both and national levels if
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translated into other languages. Many CSO networks have invested in new media (internet and
phone texting), making it possible to communicate research results directly to those in most need
of them. CSOs can see that information they provide to the public, for example on new research,
is often also read by medical professionals – who frequently do not have the time to follow all
the medical journals, which are also mostly published in English language.
“CSO cooperation helps achieve a greater impact on research policies”. This was partly
agreed by participants. “It would be nice if it were so. But sometimes you do good, and it stays
within your organisation. Cooperation doesn't always impact on policy.” Knowledge of real
needs and challenges can contribute to shaping research agendas to meet those needs. CSOs can
help to make sure research is understood and is supported by the public, including recruiting
patients in clinical trials and giving people confidence that they should be involved in the
research. “We do not want people to be involved in unethical research, but we can increase the
public image of good research, to help to understand why research is beneficial.” CSOs can also
help in quality of life measurement, eg in health technology assessment.
“Researchers help CSOs get support and legitimacy for their cause”. CSOs "need to have
evidence of what works and what doesn’t. We always work with scientific evidence. To be
effective, CSO should be evidence-based.” Data from research can strengthen policy positions
and statements. Research results provide a basis for lobbing initiatives or public health
programmes, especially when a topic or issue is contested.
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“Researchers give more scientific data and tools for use” was agreed by all participants.
CSOs provide the means to transfer knowledge to the public. However, some see their use of
research on the side of certain positions: “Research is important to support our arguments, to
prove that we are right”. They suggest that some research is too abstract or too complex: an
important reason for including CSOs in the research is to ensure that the outcomes can be
implemented in the settings where they are needed.
“Researcher cooperation helps achieve a greater impact on public policies”. There are
examples of coalitions including CSOs which have been created to push a research agenda
forward. If the general public say “we need more research”, politicians tend to listen. Public
policies are increasingly based on evidence, and research is one important source of evidence –
complemented with evidence coming from other sources, for instance the patients’ perspective.
“Researchers can help in evaluation of the effectiveness (or non-effectiveness) of CSOs'
innovative activities, e.g. services”. This was agreed mostly by CSOs providing services. It
depends on what needs to be evaluated and whether the evaluation requires a scientific construct
to be considered valid. Not all evaluation methodologies require a ‘research approach’. CSOs
also understand that the reputation of researchers can assist in demonstrating the value of their
work. CSO can benefit through experience in communication and working with media.
Researchers can invite CSOs to collaborate on dissemination, while CSOs can use researchers as
experts. Joint policy positions can be beneficial to the public and to researchers.
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4. Opportunities for researcher–CSO collaborations
Practical aspects
Equal power relationships should be established before starting a specific activity. There should
be sufficient resources available for the CSO, and their perspectives should be respected by
researchers. Researchers tend to use technical jargon, so collaboration should use language and
terminology that is understandable to all. The experience of working together can be reviewed in
a common forum of exchange, meeting and discussion, to help progress changes that need to be
made.
There should be some incentives for researchers to work with CSOs. Researchers are rewarded
from publications, but do not gain credit for involving CSOs. Perhaps research grant-giving
agencies could recommend priority in funding for proposals involving CSOs. Budgets could be
ear-marked for such collaborations and specified in research strategies and programme calls.
Where there is interest, but researchers are not experienced, there could be modules and guidance
developed to help proposers – both for researchers and CSOs.
Support for the public health field – are there more needs?
Most of the respondents considered that public health research does not receive enough support,
or indeed, that researchers gain more support than CSOs. Yet also the field is unbalanced – there
is more research on some topics than others, even where there is pressing need for effective
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policies and interventions. The reasons for weak support for public health research themselves
deserve research attention.
When new policies are introduced, there should be evaluations of their impacts and effectiveness.
There is a need to invest more in the area of prevention. Most health-research funding goes into
medico-clinical research and laboratory research: much less towards social science research on
behaviour, health determinants and socio-economic factors. Some participants expressed a
“desperate need” for data, and monitoring and evaluation of projects. Data from population
monitoring provides CSOs with evidence of need and impact. Sometimes provision of data from
national and international agencies is very slow. CSOs would like to work with researchers to
gain results more quickly. From a European perspective, some standardisation of national data
collection is needed, so that national policies can be reliably compared.
Discussion
Public health research draws on medical and social sciences in fields of epidemiology, health
promotion and policy, and health services systems and management [19]. At present, there is
more research evidence for individual, clinical-level interventions than for population and
organisational interventions [20]. Knowledge translation has sought to bring effective
interventions to practice through tasks including synthesis and summaries of research, advocacy
for its use, evaluating practice, and transforming management issues into research questions [21].
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Issues for public health research include the value of research as information input, its relevance
and ease of use, and complementarity with other factors in the policymaking process.
Health CSOs work in areas of information, policy, advocacy and service provision. They have
interests in use of knowledge that are similar to implementation sciences; but our focus has been
on how CSOs perceive the task and opportunities of research, rather than knowledge translation
itself. Studies in the USA have found that participation in research helped CSOs to influence
change, gain follow-on funding, develop skills and promote partnerships [22]. A survey of 25
AIDS/HIV community-based organizations in Ontario, Canada, found a supporting a culture that
rewarded quality improvement and research-based decision-making, but CSOs lacked resources
to find research, assess its quality and reliability, and summarize it for users [23]. In our survey,
European health CSOs wished to be involved as partners in research development, distributors of
information, helping to get participants, and as consultants on ethical issues - but generally not
directly as researchers. CSOs could particularly be involved at planning stages when issues of
relevance, cooperation and appropriate methods can be discussed and agreed. It is important for
the research to be impartial and transparent, and for its objectives and intentions – which for
health CSOs may be in the field of social innovation [3] – to be clear
The European Commission’s Science in Society Programme includes two further studies of CSO
engagement in healthcare research. EPOKS [24] is a sociological investigation across four
medical fields of the interaction between patient organisations and medical technologies, and
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how coalitions come together, organise and disseminate knowledge. HealthGovMatters [25] is
exploring perceptions and decision-making interactions between patients, care-givers, health
professionals, citizens, patient and professional organisations in relation to new technologies in
imaging, pharmaceuticals and devices in the fields of genetics and neurology. These Science in
Society studies address concerns of science as ‘physical’ technologies. Further studies are needed
of CSO as service providers in social innovation, assessing the value of information technology
in CSO activities, and determining the impact for innovation of participation in research.
Our survey was part of a wider study of public health research in Europe [12]. Telephone
interviews proved to be an appropriate method for gaining responses, with a good final response
rate from the selected organisations. While EPOKS and HealthGovMatters are collaborations
respectively between UK, Ireland, France and Portugal, and Austria, Germany and UK, STEPS
investigated perceptions of research by European-level civil society organisations and has also
engaged the 12 EU new member states with less tradition both for social research and for civil
society organisations [12].
In Europe now, both agricultural and manufacturing industry are declining relatively, while
service industries continue to grow [26]. Social innovation is increasingly important in the public
sector, where ‘soft’ innovation uses mutual exchange with society (as users and stakeholders)
rather than commercial patenting of medical technologies. In the health field especially, civil
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society organisations need to fulfil roles both of developing innovations and organising for needs
that cannot satisfactorily be met by commerce [27, 28]. European CSOs can meet this challenge,
and promote social innovation through research to serve European citizens and strengthen the
European Innovation Union.
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Key Points
 Civil society organisations form an important constituency, beyond the public sector and
business, to promote European policy for economic and social development.
 Civil society organisations do not do research themselves, but welcome collaborating in
research, using the results from research, and providing input to research agendas.
 The cultures of, and incentives for, researchers and health civil society organisations are
different, and collaboration requires building trust, a shared language, and for the power
relations and objectives to match.
 Civil society organisation should be involved at planning stages to address issues of the
study’s intentions, relevance, methods and transparency.
 Research should be developed on social innovation and in EU countries with developing
traditions for civil society engagement with health.
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